IMARA INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by IMARA INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-04-155AM Ventures VI, L.P.Enliven Therapeutics, Inc.2,366,1785.1%EDGAR
SC 13D/A2024-04-04ORBIMED ADVISORS LLCEnliven Therapeutics, Inc.8,951,46319.2%EDGAR
SC 13D/A2024-02-165AM Ventures VI, L.P.Enliven Therapeutics, Inc.3,200,6347.8%EDGAR
SC 13G/A2024-02-14PFIZER INCEnliven Therapeutics, Inc.389,4291.0%EDGAR
SC 13G/A2024-02-14Fairmount Funds Management LLCEnliven Therapeutics, Inc.2,131,3695.2%EDGAR
SC 13G/A2024-02-14CITADEL ADVISORS LLCEnliven Therapeutics, Inc.-5.7%EDGAR
SC 13G/A2024-02-14Venrock Healthcare Capital Partners III, L.P.Enliven Therapeutics, Inc.2,954,9027.2%EDGAR
SC 13G/A2024-02-14COMMODORE CAPITAL LPEnliven Therapeutics, Inc.2,901,8167.0%EDGAR
SC 13G/A2024-02-09FMR LLCEnliven Therapeutics, Inc.5,902,26514.3%EDGAR
SC 13G/A2024-02-07BML Investment Partners, L.P.Enliven Therapeutics, Inc.50,0000.1%EDGAR
SC 13D/A2024-02-025AM Ventures VI, L.P.Enliven Therapeutics, Inc.3,888,9929.4%EDGAR
SC 13D/A2023-08-285AM Ventures VI, L.P.Enliven Therapeutics, Inc.4,470,96810.9%EDGAR
SC 13G2023-05-10FMR LLCEnliven Therapeutics, Inc.4,419,58110.7%EDGAR
SC 13G2023-04-27Fairmount Funds Management LLCEnliven Therapeutics, Inc.2,124,6255.2%EDGAR
SC 13G2023-04-24COMMODORE CAPITAL LPEnliven Therapeutics, Inc.2,082,1235.1%EDGAR
SC 13G2023-03-13Venrock Healthcare Capital Partners III, L.P.Enliven Therapeutics, Inc.2,214,1425.4%EDGAR
SC 13D2023-03-065AM Ventures VI, L.P.Enliven Therapeutics, Inc.4,838,09211.8%EDGAR
SC 13G2023-03-06CITADEL ADVISORS LLCEnliven Therapeutics, Inc.-5.6%EDGAR
SC 13D2023-02-28ORBIMED ADVISORS LLCEnliven Therapeutics, Inc.8,949,33921.8%EDGAR
SC 13G/A2023-02-28COMMODORE CAPITAL LPEnliven Therapeutics, Inc.1,448,6403.5%EDGAR
External links